Search

New York: DelveInsight Business Research LLP has issued the following news release: NLRP3 Protein Inhibitors Clinical Trial Pipeline Appears Robust With 20+ Key Pharma Companies Actively Working in the Therapeutics [...]

LAS VEGAS: DelveInsight Business Research, LLP has issued the following news release: The plasma protein therapeutics market is experiencing notable growth, driven by the essential role these therapies play in [...]

Dublin: The 'Multiple Sclerosis Drugs - Global Strategic Business Report' report has been added to ResearchAndMarkets.com's offering. The global market for Multiple Sclerosis Drugs is estimated at US$21.3 Billion in [...]

M2 PRESSWIRE-May 22, 2024-: Multiple Sclerosis Market to Register Incremental Growth During the Forecast Period (2023-2032), Asserts DelveInsight | Novartis AG, Sanofi, F. Hoffmann-La Roche, Celgene Crp., Johnson & Johnson [...]

(GlobeNewswire) - The 'Multiple Sclerosis Drugs Global Market Report 2024' report has been added to ResearchAndMarkets.com's offering. The global multiple sclerosis drugs market has grown strongly in recent years. It [...]

(GlobeNewswire) - Transparency Market Research Inc. - The global injection pen market is projected to rise at a CAGR of 7.2% from 2023 to 2031. As per the report published [...]

The 'Multiple Sclerosis Drugs Global Market Report 2024' report has been added to ResearchAndMarkets.com's offering. According to a release, the global multiple sclerosis drugs market has grown strongly in recent [...]

(GlobeNewswire) - The 'Global Neurological Biomarkers Market Size, Share & Trends Analysis Report by Application (Alzheimer's, Parkinson's, Multiple Sclerosis, Autism), Type, End-use, Region, and Segment Forecasts, 2024-2030' report has been [...]

According to a recently published report by Roots Analysis, the growing demand for advanced technology to restore fundamental body movements in patients suffering from accidental injuries drives the global exoskeleton [...]

Wilmington, Delaware, United States: Transparency Market Research has issued the following news release: The autoimmune disease diagnostics market was estimated to have acquired US$ 14.4 billion in 2018. It is [...]

(GlobeNewswire) - The autoimmune disease diagnostics market was estimated to have acquired US$ 14.4 billion in 2018. It is anticipated to register a 3.8% CAGR from 2019 to 2027 and [...]

Wilmington, Delaware, United States, Sept. 22, 2023 (GLOBE NEWSWIRE) -- The autoimmune disease diagnostics market was estimated to have acquired US$ 14.4 billion in 2018. It is anticipated to register [...]

Exton, Pennsylvania, Aug. 01, 2023 (GLOBE NEWSWIRE) -- Despite outward appearances of being a stagnant market, the relapsing remitting multiple sclerosis (RMS) market continues to offer drug developers opportunities to [...]

M2 PRESSWIRE-June 27, 2023-: Multiple Sclerosis Market | Companies - Immune Response BioPharma, Clene Nanomedicine, Sanofi, Merck Healthcare KGaA, TG Therapeutics, Apimeds, Bayer HealthCare, Novartis, expected to boost the market [...]

M2 PRESSWIRE-June 26, 2023-: Multiple Sclerosis Market expected to rise | Companies - Immune Response BioPharma, Clene Nanomedicine, Sanofi, Merck Healthcare KGaA, TG Therapeutics, Apimeds, Bayer HealthCare, Novartis, Biogen (C)1994-2023 [...]

M2 PRESSWIRE-June 22, 2023-: Multiple Sclerosis Pipeline, Clinical Trials, and NDA Approvals (2023) | Companies - TG Therapeutics, Immunic, Atara Biotherapeutics, ANOKION, ImStem Biotechnology, Merck Serono, and others (C)1994-2023 M2 [...]

M2 PRESSWIRE-June 22, 2023-: Multiple Sclerosis Market: Analysis of Epidemiology, Pipeline Therapies, and Key Companies|Companies-Immune Response BioPharma, Clene Nanomedicine, Sanofi Merck Healthcare KGaA, TG Therapeutics, Inc. (C)1994-2023 M2 COMMUNICATIONS RDATE:21062023 [...]

M2 PRESSWIRE-May 29, 2023-: Relapsing Multiple Sclerosis Market expected to Rise | Companies - Novartis, Sanofi, Cinnagen, Polpharma Biologics, Immunic, Mapi Pharma, Biocad, Apimeds, Genentech (Roche), Merck (C)1994-2023 M2 COMMUNICATIONS [...]

M2 PRESSWIRE-May 25, 2023-: Secondary Progressive Multiple Sclerosis Market to Witness Growth by 2032, Estimates DelveInsight | Eli Lilly, Novartis, Sanofi, Innate Immunotherapeutics, AB Science, Opexa Therapeutics Inc, Biogen (C)1994-2023 [...]

M2 PRESSWIRE-April 26, 2023-: Relapsing-Remitting Multiple Sclerosis Pipeline Assets and Comparative Analysis of Clinical and Non-Clinical Stage Products | Major Companies - Sanofi, Remegen, Novartis, and Others (C)1994-2023 M2 COMMUNICATIONS [...]

M2 PRESSWIRE-April 19, 2023-: Propulsion of Multiple Sclerosis Pipeline as Novel and Extensive 100+ Therapies Likely to Enter in the Treatment Domain | Major Companies - Biogen, Takeda, Gilead Sciences, [...]

M2 PRESSWIRE-March 17, 2023-: Multiple Sclerosis Pipeline Analysis Demonstrates Novel 100+ Companies at the Horizon Expected to Transform the Treatment Paradigm (C)1994-2023 M2 COMMUNICATIONS RDATE:16032023 DelveInsight's, 'Multiple sclerosis Pipeline Insight [...]

M2 PRESSWIRE-March 14, 2023-: Secondary Progressive Multiple Sclerosis Market to Register Incremental Growth During the Forecast Period (2022-2032), Asserts DelveInsight | Key Companies - Sanofi, Medicinova (C)1994-2023 M2 COMMUNICATIONS RDATE:13032023 [...]

M2 PRESSWIRE-March 7, 2023-: Relapsing Remitting Multiple Sclerosis Clinical Trials Pipeline Analysis: 28+ Companies are working to improve the Treatment of Space (C)1994-2023 M2 COMMUNICATIONS RDATE:06032023 DelveInsight's, 'Relapsing Remitting Multiple [...]

M2 PRESSWIRE-January 26, 2023-: Multiple Sclerosis Pipeline Appears Robust With 100+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight (C)1994-2023 M2 COMMUNICATIONS RDATE:25012023 DelveInsight's, 'Multiple sclerosis Pipeline [...]

M2 PRESSWIRE-January 19, 2023-: Multiple Sclerosis Market to Observe Impressive Growth by (2022-2032), Evaluates DelveInsight | Key Companies - Immune Response BioPharma, Clene Nanomedicine, Sanofi, Merck Healthcare KGaA (C)1994-2023 M2 [...]

DUBLIN, Jan. 4, 2023 /PRNewswire/ -- The https://www.researchandmarkets.com/reports/4312527/protein-expression-market-size-share-and-trends?utm_source=CI&utm_medium=PressRelease&utm_code=rcwrb7&utm_campaign=1802527+-+Protein+Expression+(Prokaryotic%2c+Mammalian+Cell)+Market+Trends%2fAnalysis+Report+2022%3a+A+Global+%246.5+Billion+Market+by+2030+-+Increasing+Research+in+Proteomics+and+Genomics+Bodes+Well&utm_exec=chdo54prd report has been added toResearchAndMarkets.com's offering. The global protein expression market size is expected to reach USD 6.5 billion by 2030, expanding [...]

JERSEY CITY: InsightAce Analytic Pvt. Ltd has issued the following news release: InsightAce Analytic Pvt. Ltd. has announced the publication of a market research report titled 'Global Cannabidiol (CBD) API [...]

M2 PRESSWIRE-November 30, 2022-: Multiple Sclerosis Market in the 7mm was found to be USD 22,381 million in 2020 (C)1994-2022 M2 COMMUNICATIONS RDATE:29112022 The Multiple Sclerosis market treatment offers tremendous [...]

(GlobeNewswire) - According to a new market research report titled, Auto-Injectors Market by Product Type (Disposable Auto-injectors, Reusable Auto-injectors), by Disease Indication (Rheumatoid Arthritis, Multiple Sclerosis, Diabetes, Anaphylaxis, Others), and [...]

(GlobeNewswire) - According to the latest report published by Growth Plus Reports, the global Multiple Sclerosis Drugs Market will clock US$ 32.7 billion by 2030. The rapidly increasing adoption of [...]

NEW YORK: Growth Plus Reports has issued the following news release: According to a new market research report titled, 'Cannabis Drugs Market by Brand (Epidiolex, Marinol, Syndros, and Cesamet), by [...]

NEW YORK: The Insight Partners has issued the following news release: The Insight Partners published latest research study on 'Medical Marijuana Market Forecast to 2028 - COVID-19 Impact and Global [...]

New York, Aug 22, 2022 (GLOBE NEWSWIRE via COMTEX) -- Reportlinker.com announces the release of the report 'Global Muscle Relaxant Drugs Market: Market Segments: By Product;By Application ;and Region - [...]

NEW YORK, Aug. 19, 2022 /PRNewswire/ -- Enteral syringes are used to deliver fluids into the gastrointestinal system of patients who are physically unable to eat or swallow. These syringes [...]

DUBLIN -- The 'Autoinjectors Market Research Report by Therapy (Anaphylaxis, Diabetes, and Multiple Sclerosis), Type, Route of Administration, End User, Region (Americas, Asia-Pacific, and Europe, Middle East & Africa) - [...]

M2 PRESSWIRE-July 7, 2022-: Insights on the Autoinjectors Global Market Research Report to 2027 - Featuring Abbvie, Amgen and Antares Pharma Among Others (C)1994-2022 M2 COMMUNICATIONS RDATE:07072022 The 'Autoinjectors Market [...]

Dublin, June 27, Jun 27, 2022 (GLOBE NEWSWIRE via COMTEX) -- EQNX::TICKER_START EQNX::TICKER_END The 'Specialty Drug Distribution Market Research Report by Indication (AIDS, Hemophilia, and Multiple Sclerosis), Type, Distribution Type, [...]

DUBLIN: Research and Markets has issued the following news release: The 'Specialty Drug Distribution Market Research Report by Indication (AIDS, Hemophilia, and Multiple Sclerosis), Type, Distribution Type, Distribution Channel, State [...]

DUBLIN -- The 'Specialty Drug Distribution Market Research Report by Indication (AIDS, Hemophilia, and Multiple Sclerosis), Type, Distribution Type, Distribution Channel, State - United States Forecast to 2027 - Cumulative [...]

M2 PRESSWIRE-June 24, 2022-: US Specialty Drug Distribution Market Research Report 2022-2027: Market Set to Grow to $747.03 Million By 2027 with Compound Annual Growth at 13.99% (C)1994-2022 M2 COMMUNICATIONS [...]

M2 PRESSWIRE-May 17, 2022-: Multiple Sclerosis (MS) Market Share Analysis, Growth Opportunities and Challenges, Treatment Algorithm, Emerging Pipeline Therapies, Epidemiology Insights by DelveInsight (C)1994-2022 M2 COMMUNICATIONS RDATE:16052022 DelveInsight's 'Multiple Sclerosis [...]

M2 PRESSWIRE-April 21, 2022-: Primary Progressive Multiple Sclerosis Market Trends Analysis, Therapeutics Pipeline Outlook, and Epidemiology Insights 2032 | Key Companies - MedDay Pharma, MediciNova, Mapi Pharma, and Others (C)1994-2022 [...]

NEW YORK: Polaris Market Research has issued the following news release: Polaris Market Research recently published a research report on 'Medical Exoskeleton Market Share, Size, Trends, Industry Analysis Report, By [...]

NEW YORK, March 24, 2022 /PRNewswire/ -- Polaris Market Research recently published a research report on'Medical Exoskeleton Market Share, Size, Trends, Industry Analysis Report, By Component (Hardware, and Software); By [...]

New York, March 11, Mar 11, 2022 (GLOBE NEWSWIRE via COMTEX) -- Reportlinker.com announces the release of the report 'Multiple Sclerosis Market in US 2022-2026' - https://www.reportlinker.com/p03095494/?utm_source=GNW Our report on [...]

NEW YORK: Technavio has issued the following news release: The multiple sclerosis market in the US will be driven by factors such as strong pipeline. The market is expected to [...]

NEW YORK, March 7, 2022 /PRNewswire/ -- The multiple sclerosis market in the US will be driven by factors such as strong pipeline. The market is expected to grow by [...]

Dublin, Feb 25, 2022 (GLOBE NEWSWIRE via COMTEX) -- The 'Global Multiple Sclerosis Market - Analysis By Drug Class, Route of Administration, Distribution Channel, By Region, By Country: Market Insights, [...]